DPT

N,N-Dipropyltryptamine (DPT) is a synthetic psychedelic tryptamine that produces experiences frequently described by users as among the most intense and confrontational in the tryptamine family. Known in some communities as "the light" or "the dark tryptamine," DPT has acquired a reputation for experiences of unusual spiritual and existential depth — and unusual psychological difficulty. It is orally active (unlike DMT), though it requires substantially higher doses by the oral route than by insufflation or injection.

DPT was briefly studied clinically in the 1970s as a therapeutic agent for alcoholism and terminal illness anxiety, following in the tradition of psychedelic psychotherapy research initiated with LSD and psilocybin. This research, conducted by Gail Grof and others, identified DPT as capable of producing powerful mystical and insight experiences useful in the therapeutic context. The Temple of the True Inner Light, a syncretic religious organization based in New York, uses DPT as a sacrament and has influenced the compound's cultural reputation.

Community experience reports consistently describe DPT as heavier and more confrontational than DMT — darker in aesthetic tone, with more pronounced ego dissolution at threshold doses, and a character that many describe as challenging to work with compared to the archetypal psilocybin or LSD experience. Users report intense open-eye and closed-eye visual phenomena, profound alterations of identity and selfhood, and experiences ranging from ecstatic to deeply disturbing within the same session. Community members describing DPT explicitly note its demanding character and emphasize thorough preparation, experience with other psychedelics, and careful set and setting.